P. Ruggenenti
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes 3
- Renal Diseases and Glomerulopathies 2
- Dialysis and Renal Disease Management 2
-
- Diabetes Treatment and Management 3
- Hormonal Regulation and Hypertension 3
- Transplantation top 10%
-
- Blood Pressure and Hypertension Studies 6
-
- Renal and Vascular Pathologies 2
-
- Diet and metabolism studies 3
P. Ruggenenti
12 papers receiving 475 citations
Peers
Comparison fields: 5 of 69
- Nephrology 280
- Endocrinology, Diabetes and Metabolism 166
- Transplantation 21
- Cardiology and Cardiovascular Medicine 144
- Pulmonary and Respiratory Medicine 63
Countries citing papers authored by P. Ruggenenti
This map shows the geographic impact of P. Ruggenenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Ruggenenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Ruggenenti more than expected).
Fields of papers citing papers by P. Ruggenenti
This network shows the impact of papers produced by P. Ruggenenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Ruggenenti. The network helps show where P. Ruggenenti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Ruggenenti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 147 | |
| 2 | Trandolapril/Verapamil Sustained Release A Review of its Use in the Treatment of Essential Hypertension | 2005 | 1 |
| 3 | 2005 | 7 | |
| 4 | 2004 | 20 | |
| 5 | 1998 | 201 | |
| 6 | Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies | 1997 | 41 |
| 7 | A randomised and controlled study to assess the effect of cyclosporin in nephrotic patients with membranous nephropathy and reduced renal function (cyclomen) | 1994 | 3 |
| 8 | Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy | 1993 | 52 |
| 9 | ACE inhibitors to slow renal disease progression in diabetes: Who should be treated? | 1993 | 1 |
| 10 | A double blind, multicentre, placebo-controlled study to evaluate the effects of enalapril on the evolution of diabetic nephropathy in insulin-dependent diabetics | 1992 | 1 |
| 11 | A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies | 1991 | 11 |
| 12 | Acquired renal cystic disease and renal adenocarcinoma in long-term dialysis patients. | 1985 | 2 |
About P. Ruggenenti
P. Ruggenenti is a scholar working on Nephrology, Transplantation and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 487 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (6 papers), Diabetes Treatment and Management (3 papers), Chronic Kidney Disease and Diabetes (3 papers), Diet and metabolism studies (3 papers), Hormonal Regulation and Hypertension (3 papers), Renal and Vascular Pathologies (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Dialysis and Renal Disease Management (2 papers). The work is most often cited by research in Nephrology (280 citations), Endocrinology, Diabetes and Metabolism (166 citations) and Transplantation (21 citations). P. Ruggenenti has collaborated with scholars based in Italy, Belgium and Denmark. Frequent co-authors include Giuseppe Remuzzi, Annalisa Perna, Flavio Gaspari, Lidia Mosconi, Andrea Remuzzi, G. C. Viberti, Carmine Zoccali, Esteban Porrini, Charles J. Ferro and Gérard M. London. Their work appears in journals such as Kidney International, Nephrology Dialysis Transplantation and Journal of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.